4 research outputs found

    A VERITAS/Breakthrough Listen Search for Optical Technosignatures

    Full text link
    The Breakthrough Listen Initiative is conducting a program using multiple telescopes around the world to search for "technosignatures": artificial transmitters of extraterrestrial origin from beyond our solar system. The VERITAS Collaboration joined this program in 2018, and provides the capability to search for one particular technosignature: optical pulses of a few nanoseconds duration detectable over interstellar distances. We report here on the analysis and results of dedicated VERITAS observations of Breakthrough Listen targets conducted in 2019 and 2020 and of archival VERITAS data collected since 2012. Thirty hours of dedicated observations of 136 targets and 249 archival observations of 140 targets were analyzed and did not reveal any signals consistent with a technosignature. The results are used to place limits on the fraction of stars hosting transmitting civilizations. We also discuss the minimum-pulse sensitivity of our observations and present VERITAS observations of CALIOP: a space-based pulsed laser onboard the CALIPSO satellite. The detection of these pulses with VERITAS, using the analysis techniques developed for our technosignature search, allows a test of our analysis efficiency and serves as an important proof-of-principle.Comment: 15 pages, 7 figure

    VERITAS discovery of very high energy gamma-ray emission from S3 1227+25 and multiwavelength observations

    Full text link
    We report the detection of very high energy gamma-ray emission from the blazar S3 1227+25 (VER J1230+253) with the Very Energetic Radiation Imaging Telescope Array System (VERITAS). VERITAS observations of the source were triggered by the detection of a hard-spectrum GeV flare on May 15, 2015 with the Fermi-Large Area Telescope (LAT). A combined five-hour VERITAS exposure on May 16th and May 18th resulted in a strong 13σ\sigma detection with a differential photon spectral index, Γ\Gamma = 3.8 ±\pm 0.4, and a flux level at 9% of the Crab Nebula above 120 GeV. This also triggered target of opportunity observations with Swift, optical photometry, polarimetry and radio measurements, also presented in this work, in addition to the VERITAS and Fermi-LAT data. A temporal analysis of the gamma-ray flux during this period finds evidence of a shortest variability timescale of τobs\tau_{obs} = 6.2 ±\pm 0.9 hours, indicating emission from compact regions within the jet, and the combined gamma-ray spectrum shows no strong evidence of a spectral cut-off. An investigation into correlations between the multiwavelength observations found evidence of optical and gamma-ray correlations, suggesting a single-zone model of emission. Finally, the multiwavelength spectral energy distribution is well described by a simple one-zone leptonic synchrotron self-Compton radiation model.Comment: 18 pages, 6 figures. Accepted for publication in the Astrophysical Journal (ApJ

    The Turn-Down of the Baryonic Tully-Fisher Relation at Low Galaxy Masses

    Get PDF
    The ratio of baryonic to dark matter in present-day galaxies constrains galaxy formation theories and can be determined empirically via the baryonic Tully-Fisher relation (BTFR), which compares a galaxy's baryonic mass (Mbary_{bary}) to its maximum rotation velocity (Vmax_{max}). The BTFR is well-determined at Mbary>108_{bary}>10^8 M_{\odot}, but poorly constrained at lower masses due to small samples and the challenges of measuring rotation velocities in this regime. For 25 galaxies with high-quality data and Mbary<108_{bary}<\sim10^8 M_{\odot}, we estimate Mbary_{bary} from infrared, optical, and HI observations and Vmax from the HI gas rotation. Many of the Vmax_{max} values are lower limits because the velocities are still rising at the edge of the detected HI disks; consequently, most of our sample has lower velocities than expected from extrapolations of the BTFR at higher masses. To estimate Vmax_{max}, we map each galaxy to a dark matter halo assuming density profiles with and without cores, and find that the cored profiles match the data better. When we compare the Vmax_{max} values derived from the cored density profiles to our Mbary_{bary} measurements, we find a turndown of the BTFR at low masses that is consistent with CDM predictions and implying baryon fractions of 1-10% of the cosmic value. Although we are limited by the sample size and assumptions inherent in mapping measured rotational velocities to theoretical rotation curves, our results suggest that the galaxy formation efficiency drops at masses below Mbary108_{bary}\sim10^8 M_{\odot}, corresponding to M2001010_{200}\sim10^{10} M_{\odot}.Comment: 36 pages, 3 tables, 23 figure

    Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics

    No full text
    Abstract Novel drug discoveries have shifted the treatment paradigms of most hematological malignancies, including multiple myeloma (MM). However, this plasma cell malignancy remains incurable, and novel therapies are therefore urgently needed. Whole-genome transcriptome analyses in a large cohort of MM patients demonstrated that alterations in pre-mRNA splicing (AS) are frequent in MM. This manuscript describes approaches to identify disease-specific alterations in MM and proposes RNA-based therapeutic strategies to eradicate such alterations. As a “proof of concept”, we examined the causes of aberrant HMMR (Hyaluronan-mediated motility receptor) splicing in MM. We identified clusters of single nucleotide variations (SNVs) in the HMMR transcript where the altered splicing took place. Using bioinformatics tools, we predicted SNVs and splicing factors that potentially contribute to aberrant HMMR splicing. Based on bioinformatic analyses and validation studies, we provided the rationale for RNA-based therapeutic strategies to selectively inhibit altered HMMR splicing in MM. Since splicing is a hallmark of many cancers, strategies described herein for target identification and the design of RNA-based therapeutics that inhibit gene splicing can be applied not only to other genes in MM but also more broadly to other hematological malignancies and solid tumors as well
    corecore